Azenta Analyst Ratings
BenzingaApr 8 19:35 ET
Optimistic Financial Future and Strategic Growth: A Buy Rating for Azenta
TipRanksApr 8 16:05 ET
Analysts Conflicted on These Healthcare Names: Icon (ICLR), Schrodinger (SDGR) and Azenta (AZTA)
TipRanksApr 4 08:20 ET
Azenta Analyst Ratings
BenzingaApr 4 07:09 ET
Buy Rating Affirmed for Azenta: A Promising Future Backed by Strategic Growth Plans
TipRanksMar 28 05:35 ET
Azenta Analyst Ratings
BenzingaMar 28 05:21 ET
Azenta Analyst Ratings
BenzingaMar 14 13:20 ET
Buy Rating Affirmed: Azenta's Strong Financial Outlook and Strategic Growth Trajectory
TipRanksMar 7 05:25 ET
Azenta Analyst Ratings
BenzingaMar 7 05:09 ET
Azenta Analyst Ratings
BenzingaFeb 8 12:39 ET
Analysts Offer Insights on Healthcare Companies: Azenta (AZTA), Neurocrine (NBIX) and McKesson (MCK)
TipRanksFeb 8 05:30 ET
Azenta Analyst Ratings
BenzingaFeb 8 05:12 ET
Strong Buy Rating for Azenta, Inc. Amid Growth and Strategic Initiatives
TipRanksFeb 7 23:15 ET
Azenta Analyst Ratings
BenzingaFeb 1 11:15 ET
Optimistic Financial Outlook for Azenta: A Strong Buy Rating With Increased Target Price
TipRanksJan 22 13:18 ET
Azenta Analyst Ratings
BenzingaJan 18 13:43 ET
Needham Reiterates Buy on Azenta, Maintains $68 Price Target
BenzingaNov 14, 2023 06:21 ET
Azenta Analyst Ratings
BenzingaNov 14, 2023 06:20 ET
Analysts Conflicted on These Technology Names: Azenta (AZTA), Palo Alto Networks (PANW) and Marqeta (MQ)
TipRanksNov 14, 2023 03:00 ET
Strong Future Performance and Diversified Growth Strengthen Azenta, Inc.'s Buy Rating: An Analysis by Yuan Zhi
TipRanksNov 13, 2023 21:35 ET
No Data
No Data